Orchestra BioMed Holdings (OBIO)
NASDAQ:OBIO
US Market
Holding OBIO?
Track your performance easily

Orchestra BioMed Holdings (OBIO) Financial Statements

56 Followers

Orchestra BioMed Holdings Financial Overview

Orchestra BioMed Holdings's market cap is currently ―. The company's EPS TTM is $-1.558; its P/E ratio is -4.00; Orchestra BioMed Holdings is scheduled to report earnings on November 11, 2024, and the estimated EPS forecast is $-0.43. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Mar 24Dec 23Sep 23Jun 23
Income Statement-
Total Revenue$ 778.00K$ 620.00K$ 262.00K$ 419.00K$ 728.00K
Gross Profit$ 734.00K$ 586.00K$ 401.00K$ 378.00K$ 915.00K
EBIT$ -16.88M$ -14.42M$ -12.48M$ -14.21M$ -13.05M
EBITDA$ -16.05M$ -14.35M$ -12.41M$ -15.01M$ -13.84M
Net Income Common Stockholders$ -15.98M$ -13.46M$ -12.82M$ -13.30M$ -12.05M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 65.18M$ 75.04M$ 87.59M$ 108.85M$ 117.77M
Total Assets$ 72.38M$ 82.63M$ 95.21M$ 116.36M$ 125.88M
Total Debt$ 1.45M$ 1.62M$ 1.69M$ 11.46M$ 11.60M
Net Debt$ -63.73M$ -73.41M$ -85.91M$ -97.39M$ -106.17M
Total Liabilities$ 28.26M$ 25.44M$ 27.17M$ 36.70M$ 36.44M
Stockholders Equity$ 44.13M$ 57.19M$ 68.04M$ 79.66M$ 89.44M
Cash Flow-
Free Cash Flow$ -10.31M$ -13.12M$ -10.97M$ -10.30M$ -10.69M
Operating Cash Flow$ -10.21M$ -13.11M$ -10.97M$ -10.28M$ -10.66M
Investing Cash Flow$ 10.42M$ 5.86M$ 33.15M$ 12.95M$ 8.12M
Financing Cash Flow$ 171.00K$ 18.00K$ -10.70M$ 4.00K$ 86.00K
Currency in USD

Orchestra BioMed Holdings Earnings and Revenue History

Orchestra BioMed Holdings Debt to Assets

Orchestra BioMed Holdings Cash Flow

Orchestra BioMed Holdings Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis